Digital Pharmacist

NOVEMBER 20, 2023

The holiday season is upon us, and with this time of year comes an influx of pharmacy calls. As patients seek medication refills before they travel and inquire about vaccinations before their holiday gatherings, it’s crucial for pharmacies to optimize their Interactive Voice Response (IVR) systems. A well-thought-out IVR menu and efficient call routing can significantly enhance the customer experience and streamline operations during the busy holiday period.

Health and Personal Care Stores 105

Health and Personal Care Stores Vaccines Communication Pharmacy Management 105

STAT

NOVEMBER 24, 2023

UnitedHealth Group’s Optum division is already the largest employer of physicians in the United States, but allegations in a new lawsuit suggest Optum is hungry for more. Emanate Health, a nonprofit group of hospitals and physicians in California, filed a federal lawsuit Monday, alleging Optum pushed it to agree not to compete for primary care physicians, a violation of antitrust law.

Hospitals 362

Hospitals 362

ALiEM - Pharm Pearls

NOVEMBER 22, 2023

The toxin from the golden poison dart frog most resembles which of the following in its mechanism of action? Botulinum toxin Bufotoxin Grayanotoxin Palytoxin Tetrodotoxin Photo adapted from Wilfried Berns (Wikimedia Commons) Reveal the Answer 3. Grayanotoxin – a sodium channel opener Background The golden poison dart frog ( Phyllobates terribilis ), often considered one of the most poisonous animals on the planet, secretes onto its skin the lipophilic alkaloid batrachotoxin , which irreversibly

284

284

PharmaVoice

NOVEMBER 20, 2023

Biohaven and other companies are aiming to develop meds with a different mechanism of action that trim the waistline while building lean tissue.

280

280

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Pharmaceutical Technology

NOVEMBER 21, 2023

Texas AG has sued Pfizer and Tris Pharma for providing adulterated attention-deficit/hyperactivity disorder drug, Quillivant XR, to children.

141

141

STAT

NOVEMBER 24, 2023

Reports this week that China is experiencing a surge in respiratory infections in young children triggered flashbacks of the start of the Covid-19 pandemic among infectious disease watchers. But a rapidly organized meeting Thursday between the World Health Organization and health officials in China assuaged much of that concern. The evidence presented to the WHO team pointed to what’s sometimes called an immunity gap that was created by the pandemic.

Immunization 363

Immunization Immunity 363

European Pharmaceutical Review

NOVEMBER 24, 2023

Amgen’s new immunotherapeutic agent Tarlatamab has been shown in a Phase II trial to provide sustained anti-tumour activity in 40 percent of the small cell lung cancer patients. The international DeLLphi-301study was investigated as a new anti-cancer treatment option for patients previously considered to be beyond treatment. Results from the trial were published in the New England Journal of Medicine.

Hospitals 116

Hospitals Dosage 116

Pharma Times

NOVEMBER 20, 2023

The centre will help discover new treatments to prevent, halt and cure the condition - News - PharmaTimes

135

135

STAT

NOVEMBER 21, 2023

They have roots in 50 countries that cover more than half of the globe’s surface. They make up more than 60% of the world’s population. They speak more than 100 different languages. Yet in medical research and public health in the United States, people with Asian ancestry are almost always grouped into a single racial category. Nearly 25 million Americans — from Hmong to Laotians, and Koreans to Indonesians — have been given the same label by the U.S. government despi

Labelling 363

Labelling 363

BioPharma Dive

NOVEMBER 21, 2023

Studying somatic mutations could be “the next wave of opportunity” to develop more precise medicines, said Mike Stratton, one of Quotient’s scientific co-founders.

110

110

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

European Pharmaceutical Review

NOVEMBER 23, 2023

Boehringer Ingelheim is acquiring Swiss biotech T3 Pharmaceuticals AG (T3 Pharma), for up to £406 million (450 million CHF), boosting its immuno-oncology portfolio. The pharmaceutical company will utilise T3 Pharmaceutical’s proprietary bacterial cancer therapy platform that consisting that delivers immune-modulating bioactive proteins to cancer cells and tumour micro-environments.

Immunization 115

Immunization Immunity Pharmaceutical Companies Pharmaceutical Companies 115

The Pharmacist

NOVEMBER 22, 2023

We speak to the Pharmacist/Pharmacy Team of the Year Award shortlist ahead of this year’s General Practice Awards, to be held on 8 December in London. The first entry under the spotlight from this year’s shortlist of six is Mohammad M Rahman, principal pharmacist and head of medicines management at Lewes Primary Care Network and […] The post Meet the Pharmacist of the Year Award shortlist: Mohammad M Rahman appeared first on The Pharmacist.

106

106

STAT

NOVEMBER 23, 2023

Reports of increased respiratory disease among children in China have put disease watchers elsewhere on alert, triggering anxiety that the outbreak — if it is indeed one outbreak — holds uncomfortable echoes of the start of the Covid-19 pandemic. But at present, a number of experts say the activity has a likely explanation: China’s population, especially its young children, probably developed significant immunological susceptibility to a range of respiratory pathogens d

363

363

BioPharma Dive

NOVEMBER 22, 2023

The company said it had not found “a viable alternative” to closing down in the months since it hit a clinical setback and laid off staff.

117

117

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

European Pharmaceutical Review

NOVEMBER 21, 2023

Phase III trials of a low carbon version of GSK’s metered dose inhaler, Ventolin (salbutamol), using a next generation, lower carbon propellant, are set to start in 2024. The pharma company stated that if successful, it has the potential to reduce greenhouse gas emissions from use of the inhaler by approximately 90 percent. According to GSK, thirty-five million patients with respiratory conditions globally relying on its metered dose inhaler.

116

116

Pharmafile

NOVEMBER 24, 2023

Alladapt Immunotherapeutics has announced that ADP101 has received Fast Track Designation from the US Food and Drug Administration (FDA) as a treatment for one or more food allergens. ADP101 is currently the most advanced multi-food oral immunotherapy (mOIT) candidate in development, and there are currently no FDA-approved OIT treatments for multi-food allergy to foods other […] The post Alladapt Immunotherapeutics gains FDA Fast Track Designation for ADP101 as food allergy treatment appea

105

105

STAT

NOVEMBER 21, 2023

Pharmacies could be called the most “rock solid” entity in our health care system. Even before Covid, pharmacies were held in high esteem; during the pandemic, they raised their game by making it easy for tens of millions of Americans to get vaccinated, fulfilling a long-standing ambition of pharmacists to provide more expansive clinical services.

Vaccines 352

Vaccines 352

The Guardian - Pharmaceutical Industry

NOVEMBER 20, 2023

People should not die because of their income or where they were born. We must have the courage to stand up to the pharmaceutical industry Here is a simple moral proposition. No one in America, or anywhere in the world, should die or suffer unnecessarily because they cannot afford a prescription drug which, in many cases, costs a few cents or a few dollars to manufacture.

112

112

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

NOVEMBER 21, 2023

SMPaeds2 aims to advance precision medicines for children with relapsed cancer - News - PharmaTimes

137

137

Express Pharma

NOVEMBER 22, 2023

Strides Pharma Science announced that its step‐ down wholly owned subsidiary, Strides Pharma Global Pte., Singapore, has received approval for Sodium Sulphate, Potassium Sulphate and Magnesium Sulphate Oral Solution 17.5g/ 3.13g/ 1.6g per 6 ounces (Product) from the United States Food & Drug Administration (USFDA). The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Suprep Bowel Prep Kit Oral Solution 17.5g/ 3.13g/ 1.6g per 6 ounces of Braintree La

105

105

STAT

NOVEMBER 20, 2023

In the depths of the Covid-19 pandemic, something strange happened: For a year or two, illnesses that used to emerge like clockwork when fall and winter arrived — flu, RSV, and the myriad viruses that cause colds — did not sicken us. The cause now appears clear: The measures we took to avoid the new disease, including isolating and social distancing, muscled most other respiratory pathogens out of the cold-and-flu-season picture.

363

363

BioPharma Dive

NOVEMBER 20, 2023

Called Evinova, the unit will operate as a separate business within AstraZeneca, which sees digital health solutions as a market primed for growth.

116

116

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

The Guardian - Pharmaceutical Industry

NOVEMBER 18, 2023

Drug firm Novo Nordisk proposed singling out those most likely to return to work with its weight-loss injection Obesity jab maker Novo Nordisk suggested to senior government officials that they could “profile” benefit claimants so that those most likely to return to work could be targeted with its weight-loss injections. Internal documents obtained by the Observer reveal that Pinder Sahota, corporate vice-president of Novo Nordisk UK, told the then health secretary Steve Barclay, England’s chief

Documentation 111

Documentation 111

European Pharmaceutical Review

NOVEMBER 23, 2023

Following the UK government’s recent announcement of a £520 million funding boost for UK manufacturing, a new Oligonucleotide Manufacturing Innovation Centre of Excellence in Scotland will develop innovative and sustainable techniques for these medicines. According to the Centre for Process Innovation (CPI), oligonucleotides therapeutics use short, chemically synthesised fragments of DNA or RNA to modulate protein expression and ultimately treat the underlying cause of disease.

Packaging 104

Packaging 104

STAT

NOVEMBER 21, 2023

Few people leave the world with as much grace or influence as Rosalynn Smith Carter, who died Sunday at the age of 96. While she called her autobiography “The First Lady of Plains,” to many she was also the first lady of mental health reform. Decades ago, she took bold stances on mental health topics that, today, have become conventional wisdom: Mental health is health, stigma is deadly, and people with mental illness deserve to be part of society instead of hidden away in overcrow

348

348

Pharma Times

NOVEMBER 22, 2023

The trial will use an AI screening platform to identify those most at risk of dementia - News - PharmaTimes

129

129

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharmaceutical Technology

NOVEMBER 22, 2023

The funding will go towards the development of the company's four CNS candidates, with Phase II study data readouts expected by early 2025.

116

116

BioPharma Dive

NOVEMBER 20, 2023

The regulator plans to convene an advisory panel to discuss an expanded indication for Abecma, presenting another hurdle for Bristol Myers and partner 2seventy bio.

107

107

STAT

NOVEMBER 18, 2023

The revolution started in silence. Jennifer Doudna and Emmanuelle Charpentier, now Nobelists , published their first paper announcing a new enzyme for editing DNA in Science in June 2012. It was called CRISPR-Cas9. It wasn’t until January 2013 that the first paper showing the enzyme would work in cells, from Feng Zhang, was published, also in Science.

363

363

Pharma Times

NOVEMBER 23, 2023

Both companies will use their platforms to accelerate drug discovery and development - News - PharmaTimes

130

130

pharmaphorum

NOVEMBER 23, 2023

US biotech Moderna has completed the installation of its clinical laboratories at its new R&D facility in the UK dedicated to the discovery of new mRNA vaccines and therapeutics, part of a 10-year partnership with the government agreed last year that has been estimated to be worth around £1 billion.

Vaccines 105

Vaccines 105